New York, New York, United States The leading representative office of defined VC is situated in the New York. The company was established in North America in United States.
The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Perseus-Soros Biopharmaceutical Fund, startups are often financed by InterWest Partners, HealthCare Ventures, Frazier Healthcare Partners. The meaningful sponsors for the fund in investment in the same round are HealthCare Ventures, Montreux Equity Partners, Schroder Ventures. In the next rounds fund is usually obtained by Roche Venture Fund, L Capital Partners, HealthCare Ventures.
We can highlight the next thriving fund investment areas, such as Health Diagnostics, Biopharma. The fund has exact preference in some founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline Auxilium Pharmaceuticals, Myogen, CeNeRx BioPharma Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The top activity for fund was in 2004. Deals in the range of 10 - 50 millions dollars are the general things for fund. Considering the real fund results, this VC is 3 percentage points less often commits exit comparing to other organizations. This Perseus-Soros Biopharmaceutical Fund works on 10 percentage points more the average amount of lead investments comparing to the other organizations. The top amount of exits for fund were in 2012. The fund is constantly included in less than 2 investment rounds annually.
Related Funds
| Fund Name | Location |
| Amesto Solutions | Norway, Oslo |
| Angivest Ventures | - |
| Cadron Capital Partners | Arkansas, Conway, United States |
| Catalyst Growth Partners | California, United States, Yucca Valley |
| Charles L. Shor Foundation | - |
| E City Ventures | India, Maharashtra, Mumbai |
| Orion Corporation | Espoo, Finland, Uusimaa |
| Philip Morris International | New York, New York, United States |
| Rytu Invest | - |
| Schottenstein Stores | Columbus, Ohio, United States |
| Shrug Capital | California, San Francisco, United States |
| Socadif | - |
| SPARK Impact | - |
| Thomson multimedia | Dallas, Texas, United States |
| Ventura Investment | Dresden, Germany, Sachsen |
| Walnut Street Capital Fund I, L.P. | California, San Francisco, United States |
| Wells Fargo Startup Accelerator | California, San Francisco, United States |
| WizEvo | China, Guangdong, Shenzhen |
| Xmark Asset Management | New York, New York, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
| $15M | 29 Sep 2008 | Cary, North Carolina, United States | |||
Cardiokine | $50M | 01 May 2006 | Philadelphia, Pennsylvania, United States | ||
| $8M | 14 Nov 2005 | Cary, North Carolina, United States | |||
Ambit Biosciences | $31M | 12 May 2005 | San Diego, California, United States | ||
ArgiNOx Phamaceuticals,Inc. | $25M | 02 Mar 2005 | Redwood City, California, United States | ||
| $48M | 05 Aug 2004 | Carlsbad, California, United States | |||
ArgiNOx Phamaceuticals,Inc. | $8M | 12 Jun 2004 | Redwood City, California, United States | ||
Cardiokine | $37M | 13 Apr 2004 | Philadelphia, Pennsylvania, United States | ||
Oculex Pharmaceuticals | $50M | 22 Oct 2002 | Sunnyvale, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
| $15M | 29 Sep 2008 | Cary, North Carolina, United States | |||
Cardiokine | $50M | 01 May 2006 | Philadelphia, Pennsylvania, United States | ||
| $8M | 14 Nov 2005 | Cary, North Carolina, United States | |||
Ambit Biosciences | $31M | 12 May 2005 | San Diego, California, United States | ||
ArgiNOx Phamaceuticals,Inc. | $25M | 02 Mar 2005 | Redwood City, California, United States | ||
| $48M | 05 Aug 2004 | Carlsbad, California, United States | |||
ArgiNOx Phamaceuticals,Inc. | $8M | 12 Jun 2004 | Redwood City, California, United States | ||
Cardiokine | $37M | 13 Apr 2004 | Philadelphia, Pennsylvania, United States | ||
Oculex Pharmaceuticals | $50M | 22 Oct 2002 | Sunnyvale, California, United States |
